Michael Waarts, PhD

Scientist, Astellas Pharma
Michael Waarts
Email
[email protected]
Dissertation
Identification Of Therapeutic Targets In Clonal Hematopoiesis
Mentor
Ross L. Levine, MD
Start Year
2018
End Year
2025
Education
BS, University of Chicago; Cancer Biology

Fellowships

  • Geoffrey Beene Graduate Student Fellowship (2019-2020)
  • Ruth L. Kirschstein Predoctoral Individual National Research Service Fellowship, NIH National Cancer Institute (2021-2024)
  • NCI Predoctoral to Postdoctoral Fellow Transition Award, F99/K00 (2022-2024)
Publications

Waarts MR, Stonestrom AJ, Park YC, Levine RL. (2022) Targeting mutations in cancer. J Clin Invest

Xiao W, Chan A, Waarts MR, Mishra T, Liu Y, Cai SF, Yao J, Gao Q, Bowman RL, Koche RP, Csete IS, DelGaudio NL, Derkach A, Baik J, Yanis S, Famulare CA, Patel M, Arcila ME, Stahl M, Rampal R, Tallman MS, Zhang Y, Dogan A, Goldberg AD, Roshal M, Levine RL. (2020) Plasmacytoid dendritic cell expansion defines a distinct subset of TUNX1 mutated acute myeloid leukemia. Blood. [Online ahead of print]

View a full listing of Michael Waarts’ journal articles.